Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS.
Saved in:
| Title: | Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS. |
|---|---|
| Authors: | Weinstock-Guttman B; Jacobs Neurological Institute, Buffalo, NY 14203-1126, USA. bguttman@thejni.org, Galetta SL, Giovannoni G, Havrdova E, Hutchinson M, Kappos L, O'Connor PW, Phillips JT, Polman C, Stuart WH, Lynn F, Hotermans C |
| Source: | Journal of neurology [J Neurol] 2012 May; Vol. 259 (5), pp. 898-905. Date of Electronic Publication: 2011 Oct 19. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
